Merit Medical Systems announces $136.1 million in 3Q revenue

Merit Medical Systems, a Utah-based manufacturer of disposable medical devices used in imaging, announced its third-quarter earnings this week, including $136.1 million in revenue, which is up from $128.8 million in 2014.

The company also reported non-GAAP net income of $8.9 million for the quarter, or $0.20 earnings per share (EPS). That’s down from $10.7 million, or $0.25 EPS, in 2014.

“The third quarter, as we discussed in our second quarter call, had most of the elements of a ‘summer quarter,’” Fred P. Lampropoulos, Merit chairman and CEO, said in a statement. “Revenues for the third quarter of 2015 were down approximately $2 million from the second quarter of 2015, but were up 6 percent from the third quarter of 2014. As could be expected, contribution was lower, and consequently, gross margins were affected. But more importantly, we view this as a seasonal phenomenon and now behind us.”

Chicago-based Barrington Research Associates upgraded Merit’s stocks to "outperform” status in the days after the earnings announcement.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.